Delivery Order HHSN261201000071I-HHSN26100001
Award Date
9/17/10
Potential Completion Date
9/30/14
Potential Value
$193K
Federal Agency
National Cancer Institute
Awardee
Melanoma Institute Australia
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...
This is a Firm Fixed Price Delivery Order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Indivumed, Inc., a For Profit Organization. The contract is for the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The potential value of this contract is $38,000.00. It is not associated with a set-aside designation. The contract is issued under the NCI Cancer Genome...
This is a $23,500 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Singapore Health Services PTE LTD, a Singapore-based non-profit organization. The contract is for the provision of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the NCI's research efforts. The contract is not designated as a set-aside. It is a task order under the NCI Cancer Genome Atlas Program Tissue Purchase master...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer, a non-profit organization and foundation in Spain. The $6,000 contract is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is a joint effort between the National...
This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. for the Cancer Genome Atlas (TCGA) program. The $1,337,077.50 contract is to provide tissue samples and data from various types of cancer for the TCGA program, which aims to characterize the genomic changes involved in cancer. The award is not associated with a set-aside program. This delivery order is part of...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Cureline Inc., a woman-owned small business. The contract is for the procurement of breast ductal, colon, head and neck, lung adenocarcinoma, lung squamous, kidney renal, stomach, uterine corpus, and melanoma tissue samples under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The contract has a ceiling value of $212,610.63 and a completion date of January 24,...
This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie (Centrum Onkologii) in Poland. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ, with a ceiling value of $336,000.00 and a period of performance ending on September 30, 2014. The contract is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA)...